SIU Scientific Programme 2018

Thursday, October 04

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0715-1615

SYMP-01: World Urologic Oncology Federation

Room: 5F Baekdu D
Chair: Laurence Klotz, Canada

To view a PDF of the WUOF programme, please click here.

0715-0745		Meet and Greet International Colleagues (coffee and refreshments served)
0745-0750		Framing of Theme Laurence Klotz, Canada
0750-0910		SESSION I: Prostate Cancer Screening and Prevention Moderators Laurence Klotz, Canada Ji Youl Lee, South Korea
0755-0802		Prostate Cancer Screening: European Perspective Franz Recker, Switzerland
0805-0812		Prostate Cancer Screening: American Perspective Matthew Cooperberg, United States
0815-0822		Prostate Cancer Screening: Japanese Perspective Shin Egawa, Japan
0825-0832		Prostate Cancer Screening: Latin American Perspective Arturo Mendoza-Valdes, Mexico
0835-0842		PSA Cutpoint Should be 1.5 E. David Crawford, United States
0845-0852		FSH and Prostate Cancer Jehonathan Pinthus, Canada
0900-0910		Discussion
0910-1040		SESSION II: Prostate Cancer Management Options Moderators Yves Fradet, Canada Sung Kyu Hong, South Korea
		CASE & DEBATE – MANAGEMENT OF GRADE GROUP 2 PROSTATE CANCER
0915-0925		Surveillance Sung Kyu Hong, South Korea
0925-0935		Focal Therapy Rafael Sanchez-Salas, Canada
0935-0945		Radical Therapy Neil Fleshner, Canada
0945-0955		Discussion
0955-1007		Can Ultrasound Imaging Replace MRI? Peter Hammerer, Germany
1007-1019		Can MRI Replace Prostate Biopsy? Guillaume Ploussard, France
1019-1029		Integrating Imaging and Biomarkers in Prostate Cancer Diagnosis Derya Tilki, Germany
1029-1040		Discussion
1040-1135		SESSION III: Kidney Cancer Moderators Alessandro Volpe, Italy Ofer Yossepowitch, Israel
1042-1054		Challenges in Cystic Renal Tumours
1054-1106		Angiogenesis Markers in RCC Hanjong Ahn, South Korea
1106-1118		Where to Draw the Line Between Radical and Partial Nephrectomy? Peter Mulders, The Netherlands
1118-1130		Adjuvent Therapy in RCC Post Nephrectomy Robert Flanigan, United States
1130-1135		Discussion
1135-1200		Working Lunch (Complimentary Meal to All Seated Participants Attending Session Four Working Lunch)
1200-1330		SESSION IV: Town Hall—Emerging Diagnostic Biomarkers in Prostate Cancer Moderator: Laurence Klotz, Canada
1200-1210		Introduction: The Unmet Need for Liquid Biopsy in the Diagnostic Pathway Matthew Cooperberg, United States
1210-1239		BENCH TO BEDSIDE: WHAT IS THE LATEST DATA ON EMERGING BIOMARKERS?
1210-1220		Urinary Micro RNAs and SNOs as a Prostate Cancer Biomarker Platform Martin Tenniswood, United States
1220-1230		Emerging Biomarkers in Prostate Cancer Jack Schalken, The Netherlands
1230-1240		Radiogenomics Robert Reiter, United States
1240-1300		PANELISTS: BIOMARKERS IN PROSTATE CANCER: Current Role of Molecular Biomarkers in the Management of Prostate Cancer: Which Ones and Why?
1240-1245		Panelist 1 Shin Egawa, Japan
1245-1250		Panelist 2 Marc Dall'Era, United States
1250-1255		Panelist 3 Robert Reiter, United States
1255-1300		Panelist 4 Derya Tilki, Germany
1300-1330		Open Discussion
1330-1420		SESSION V: Prostate Cancer Treatment Options Moderators Damien Bolton, Australia John Davis, United States
1332-1344		Improving the Outcome of Men on Active Surveillance Marc Dall'Era, United States
1344-1356		RP in Men Over Age 75: Is it Folly? Shomik Sengupta, Australia
1356-1408		Advances in MR-U/S Fusion Guided Ardeshir Rastinehad, United States
1408-1418		Discussion
1420-1520		SESSION VI: Urothelial Cancer Moderators Michael Leveridge, Canada Robert Siemens, Canada
1422-1434		Liquid Biopsy for Bladder Cancer Prognosis Peter Black, Canada
1434-1446		Impact of Urinary Marker Testing in Bladder Cancer Badrinath Konety, United States
1446-1458		Clinical Implications of Mutational Profiling of Invasive Bladder Cancer Seth Lerner, United States
1458-1510		Should Variant Histology Change Management of Bladder Cancer? Ashish M. Kamat, United States
1510-1520		Discussion
1520-1615		SESSION VII: Advanced Prostate Cancer Moderator: Marcelo Luiz Bendhack, Brazil
1522-1534		Medical Tourism in Urologic Oncology: Korean Perspective Ji Youl Lee, South Korea
1534-1546		PSMA in the Management of Patients with Biochemical Failure Shrawan Kumar Singh, India
1546-1558		Chemotherapy and Radium for CRP - Role in the Era of ARTs Peter Black, Canada
1538-1615		How to Reduce Errors in Scientific Research Laurence Klotz, Canada

0730-1430

LS: SIU eGrand Rounds on Stone Disease and BPO

Room: 5F Baekdu A+B
Chair: Jean de la Rosette, Türkiye

0800-1630

SYMP-05: Korean Urological Association Symposium (in Korean)

Room: 4F Baekje 2/3/4
Chair: Cheol Kwak, South Korea

0800-0805		Welcome Remarks and Introduction Jun Cheon, South Korea
0805-0920		SESSION I: Bladder Cancer Moderators Jin Seon Cho, South Korea Cheol Kwak, South Korea
0805-0820		Gut Microbiome and Immunotherapy Seok Joong Yun, South Korea
0820-0835		Significance of Histologic Variants Ja Hyeon Ku, South Korea
0835-0850		Robotic-Assisted Radical Cystectomy in Korea Seok Ho Kang, South Korea
0850-0905		Immune Checkpoint Inhibitors for Bladder Cancer in Korea Ho Kyung Seo, South Korea
0905-0920		Panel Discussion Discussants Beom Sik Hong, South Korea Byong Chang Jeong, South Korea Moon Ki Jo, South Korea
0920-1035		SESSION II: Minimally Invasive Surgery for Renal Cell Carcinoma Moderators Youn Soo Jeon, South Korea Tae Gyun Kwon, South Korea
0920-0935		Laparoscopic IVC Thrombectomy Sung-Hoo Hong, South Korea
0935-0950		My Surgical Tip of Robot-Assisted Partial Nephrectomy Cheryn Song, South Korea
0950-1005		The Role of Robotic/Laparoscopic Surgery in the Management of Cystic RCC Jae Young Park, South Korea
1005-1020		da Vinci Xi Single Port Partial Nephrectomy Woong Kyu Han, South Korea
1020-1035		Panel Discussion Discussants Jinsoo Chung, South Korea Seong Il Seo, South Korea
1035-1150		SESSION III: Prostate Cancer Moderators Sung Kyu Hong, South Korea Ji Youl Lee, South Korea
1035-1050		Prostate Cancer: Does Race Matter? In Gab Jeong, South Korea
1050-1105		How Does PET Scan Help in the Management of Prostate Cancer? Nathan Lawrentschuk, Australia
1105-1135		Are We Ready for Focal Therapy in Prostate Cancer?
		Yes Hwang Gyun Jeon, South Korea
		No U-Syn Ha, South Korea
1135-1150		Panel Discussion Jae Young Joung, South Korea Taek Won Kang, South Korea Yong Hwii Ko, South Korea
1150-1240		Break
1240-1355		SESSION IV: Aging Lower Urinary Tract (In English) Moderators Dae Kyung Kim, South Korea Claus Roehrborn, United States
1240-1255		Basic Physiology of Aging Lower Urinary Tract Yun Seob Song, South Korea
1255-1310		Special Considerations in the Management of Frail Elderly Population Su-Jin Kim, South Korea
1310-1325		Management of Bladder Outlet Obstruction in Underactive Bladder Eun Sang Yoo, South Korea
1325-1340		Timing of Intervention for LUTS/BPO/BPE and BPH: Do We Have it Right? Claus Roehrborn, United States
1340-1355		Panel Discussion Discussants Su-Jin Kim, South Korea Yun Seob Song, South Korea Eun Sang Yoo, South Korea
1355-1510		SESSION V: Erectile Dysfunction after Radical Prostatectomy Moderators Du Geon Moon, South Korea Dae Yul Yang, South Korea
1355-1410		Update on Basic/Translational Research for ED after Radical Prostatectomy Ji-Kan Ryu, South Korea
1410-1425		Current Status of Clinical Role of Penile Rehabilitation Won Ki Lee, South Korea
1425-1440		Options after Initial PDE5 Inhibitor Failure Min Chul Cho, South Korea
1440-1455		Surgical Tips for Penile Prosthesis Implantation after Radical Prostatectomy Hong Seok Shin, South Korea
1455-1510		Panel Discussion with Clinical Case Panelists Soo-Woong Kim, South Korea Ki Hak Moon, South Korea Presenter: Jun Nyung Lee, South Korea
1510-1625		SESSION VI: Practice Issues of Pediatric Diseases in Adolescent and Adult Patients Moderators Chang Hee Han, South Korea Sang Don Lee, South Korea
1510-1525		Vesicoureteral Reflux Sang Hoon Song, 대한민국
1525-1540		Hydronephrosis (Ureteropelvic Junction Obstruction) Young Jae Im, South Korea
1540-1555		Nocturnal Enuresis Jae Min Chung, South Korea
1555-1610		Hypospadias Sang Woon Kim, South Korea
1610-1625		Panel Discussion Discussants Minki Baek, South Korea Jung Yoon Kang, South Korea Jun Mo Kim, South Korea Kwanjin Park, South Korea
1625-1630		Closing Remarks Jun Cheon, South Korea

0800-1630

SYMP-02: Urology in Asia

Room: 5F Baekdu C
Co-Chairs: Shin Egawa, Japan / Sang Won Han, South Korea

0800-0805		Welcome Remarks and Introduction Allen W. Chiu, Taiwan Sang Won Han, South Korea
0805-0920		SESSION I: Functional Urology in Asia Moderators Jun Hyuk Hong, South Korea Jang Hwan Kim, South Korea
0805-0820		New Technology for LUTS Research Tack Lee, South Korea
0820-0835		Update of Clinical Insights on Storage Symptoms: How to Increase Adherence and Outcomes? Jose Buenaventura Reyes, Philippines
0835-0850		Mixed Urinary Incontinence: What First? Jeremy Yuen-Chun Teoh, Hong Kong
0850-0905		Controversy on Incontinence in Males: Pelvic Floor Training, Medication, and Surgery Hana Yoon, South Korea
0905-0920		Panel Discussion Discussants Jose Buenaventura Reyes, Philippines Tack Lee, South Korea Jeremy Yuen-Chun Teoh, Hong Kong
0920-1035		SESSION II: Endourology Moderators Tae Hyo Kim, South Korea Seiji Naito, Japan
0920-0935		Role of Flexible Ureteroscope and PCNL in Patients with Anomalous Upper Urinary Tract Mahesh R. Desai, India
0935-0950		Current Trend of Managing Pediatric Urinary Stones/New Technologies in RIRS Deok Hyun Han, South Korea
0950-1005		Super-Mini-PCNL Guohua Zeng, China
1005-1020		How to Minimize Complication while Maximizing Outcomes of RIRS Bannakij Lojanapiwat, Thailand
1020-1035		Panel Discussion (Case Presentations) Discussants Chaidir Mochtar, Indonesia Jeremy Yuen-Chun Teoh, Hong Kong Young Eun Yoon, South Korea
1035-1150		SESSION III: Infection Moderators Yong Hyun Cho, South Korea Tetsuro Matsumoto, Japan
1035-1050		Global Prevalence of Urogenital Tract Infections: Emerging Threats Dong Hoon Lim, South Korea
1050-1105		Prevention of Perioperative Infections in the Urological Field Shingo Yamamoto, Japan
1105-1120		Mycoplasma Genitalium: An Important Emerging STI Seung-Ju Lee, South Korea
1120-1135		Treatment Strategies for Genital Lesions of STI Shrawan Kumar Singh, India
1135-1150		Panel Discussion Discussants Seung-Ju Lee, South Korea Dong Hoon Lim, South Korea Shrawan Kumar Singh, India Shingo Yamamoto, Japan
1150-1250		Break
1250-1405		SESSION IV: New Technologies in the Management of Prostate Cancer Moderators Shin Egawa, Japan Gyung Tak Mario Sung, South Korea
1250-1305		Advanced Prostate Cancer Registry from 8 Asian Countries Yeong-Shiau Pu, Taiwan
1305-1320		HIFU for Prostate Cancer: Current Status and Outcomes Sunao Shoji, Japan
1320-1335		Development of New Robotics Platforms for Prostate Cancer Koon Ho Rha, South Korea
1335-1350		Emerging Technology in Prostate Cancer Radiation Therapy Young Seok Kim, South Korea
1350-1405		Panel Discussion Discussants Sang Hyeon Cheon, South Korea Sung Kyu Hong, South Korea Jason Letran, Philippines
1405-1520		SESSION V: Kidney Cancer Moderators Masatoshi Eto, Japan Seong Il Seo, South Korea
1405-1420		Therapeutic Vaccine for Renal Cell Carcinoma Selvalingam Sothilingam, Malaysia
1420-1435		Current Status and Future Perspectives regarding Biomarkers for Renal Cell Carcinoma Masatoshi Eto, Japan
1435-1450		Longitudinal Changes in Renal Function after Radical Nephrectomy and Risk Factors for Postoperative Severe Renal Impairment Jeong-Hyun Kim, South Korea
1450-1505		Percutaneous Therapies in Small Renal Mass
1505-1520		Panel Discussion Discussants Keong Tatt Foo, Singapore Robin Joshi, Nepal Jeong-Hyun Kim, South Korea Rohan Malek, Malaysia
1520-1635		SESSION VI: Emerging Treatment Modalities in Long Standing Disease: Peyronie's Disease Moderators Hyun Jun Park, South Korea Rainy Umbas, Indonesia
1520-1535		Extracorporeal Shock Wave Therapy: Pros Min Gu Park, South Korea
1535-1550		Extracorporeal Shock Wave Therapy: Cons Hong-Chiang Chang, 台灣
1550-1605		Collagenase Clostridium Histolyticum: Pros
1605-1620		Collagenase Clostridium Histolyticum: Cons Mai Ba Tien Dung, Vietnam
1620-1630		Panel Discussion Discussants Hong-Chiang Chang, 台灣 Mai Ba Tien Dung, Vietnam Min Gu Park, South Korea Mohammad Ali Sadighi Gilani, Iran

0800-1200

SYMP-04: 7th Symposium on Affordable New Technologies in Urology (SANTU) & 2nd Best Affordable New Technologies in Urology Contest (BANTUC)

Room: 4F Baekje 6
Chair: Mohammed Lezrek, Morocco
Co-Chair: Christian Bach, Germany
Honorary Chair: Daniel Yachia, Israel

0700-0845		Poster Viewing
0845-0855		Opening SANTU 7 Mohammed Lezrek, Morocco
0855-1110		SANTU Lectures
0855-0910		Using Modern Technology to Promote Surgical Care in Developing Countries Christian Bach, Germany
0910-0920		ePoster Presentations
		Cost-Utility Analysis of Upfront Pharmacotherapy Compared to an Upfront Surgical Intervention for Patients with Benign Prostate Hyperplasia Dean Elterman, Canada
		Cystoscopic Stent Removal Using Smartphone Shanky Singh, India
		A Novel Mobile Acoustic Uroflowmetry: Comparison of Uroflowmetry and Mobile Acoustic Uroflowmetry Young Ju Lee, South Korea
0920-0935		How to Set Up a Sustainable Endourology Programme in a Middle Income Country Hichem Kouicem, Algeria
0935-0945		ePoster Presentations
		The Use of Unconventional Instruments in Emergency Room of Urology Petrisor Aurelian Geavlete, Romania
		Small Steps, Hand-in-Hand, Leaving No One Behind—One Possible Solution to the Growing Disparity in Global Surgery: The West African Experience Emmanuel Abara, Canada
		To Assess the Efficacy of Lidocaine Jelly in Preventing Stone Fragment Retropulsion During Ureteroscopic Lithotripsy for Ureteral Stones: A Systemic Review and Meta-Analysis Kunpeng Shu, China
0945-1000		Re-Use and Re-Cycle: Saving Resources in Developing Countries Daniel Yachia, Israel
1000-1010		ePoster Presentations
		Vessel Sparing Anastomotic Urethroplasty for Pelvic Fracture Urethral Distraction Defects Pankaj Joshi, India
		Success of TURP in Urodynamically Proven Hypo Contractile Bladders Gopesh Bishnoi, India
		Percutaneous Tract Dilation Training on a Pumpkin Mohammed Lezrek, Morocco
1010-1025		The Economic Benefits of Teaching Urology in Low- and Middle-Income Countries Kurt McCammon, United States
1025-1035		ePoster Presentations
		BTSK Model of Teaching PCNL to Trainee Pratikkumar Shah, India
		Trichosanthes Kirilowii Fruits as a Therapeutic Agent for Urothelial Carcinoma of the Bladder Ning Jiang, China
		Platelet Rich Plasma in Erectile Dysfunction Raouf Salti, France
1035-1050		Think Out of the Box—How to Find New Solutions for Old Problems in Endourology Mohammed Lezrek, Morocco
1050-1150		2nd Best Affordable New Technologies in Urology Contest (BANTUC)
1050-1055		Presentation of the 2nd Best Affordable New Technologies in Urology Contest Daniel Yachia, Israel
1055-1145		Presentation of Projects by Finalists
		Ultra-Low-Cost Wireless Endoscopic Camera John Lazarus, South Africa
		Laparoscopic Ureteric Stent Guider (LUSG) Mohamed Al Ameedee, Iraq
		14G Angiocath as Needle Guide in Freehand Ka Lun Lo, China
		Cost Effective “Three in one” Chicken Carcass Model for Training in Laparoscopic Urologic Procedures Arvind Ganpule, India
		A Novel Disposable and Cost Effective (DICE) Nephroscope for Affordable PCNL Regi Septian, Indonesia
		Infant Feeding Tube as Rectal Bulb Catheter for Abdominal Pressure Monitoring Amit Jain, India
		Light When There Is No Light Ganesh Prasad Sankarapandian, India
		Question and Answer
1145-1150		Announcement of results and award distributions for BANTUC Daniel Yachia, Israel
1150-1155		Award distributions for the Best Moderated Poster, Best Un-moderated Poster and Best Video presentations Mohammed Lezrek, Morocco
		Closing SANTU-7 Mohammed Lezrek, Morocco
		Invitation to SANTU-8 2019 and 3rd Best Affordable New Technologies in Urology Contest Daniel Yachia, Israel

0800-1100

INN: SIU Innovators' Symposium

Room: 5F Goguryeo 1/2/3
Co-Chairs: Shusuke Akamatsu, Japan / M. Hadi Radfar, Iran
Social Media Moderator: Amanda Chung, Australia

At the end of this session, the learner will:

Summarize the future application of virtual and augmented reality in urologic oncology.
Compare pros and cons of image-guided procedures versus traditional standard procedures
Discuss early career challenges for a young urologist

0800-0900		Part 1: Virtual and Augmented Reality in Urologic Surgery Moderators Peter Black, Canada M. Hadi Radfar, Iran
0800-0807		Navigation System for Robotic Assisted Partial Nephrectomy Atsuro Sawada, Japan
0807-0814		Patient-Specific 3D Print Kidney Models for Robotic Assisted Partial Nephrectomy Fumiya Hongo, Japan
0814-0821		A Real-Time Support System for Robotic-assisted Radical Prostatectomy using MRI-based Virtual Reality Models Sherif Mehralivand, United States
0821-0828		Indigenous Innovations: Making PCNL Simulation Affordable
0828-0838		Future of Robotic Surgery in Urology Koon Ho Rha, South Korea
0838-0900		Panel Discussion
0900-1000		Part 2: How has Image-Guided Urology Changed Practice? Moderators Shusuke Akamatsu, Japan Nathan Lawrentschuk, Australia
		Debate—Small Renal Mass
		Partial Nephrectomy Henry Ho, Singapore
		Ablative Therapy Homayoun Zargar, Australia
		Debate: Prostate Cancer Diagnosis
		TRUS Biopsy Andrés Hernández-Porras, Mexico
		MRI-TRUS Fusion Biopsy Guillaume Ploussard, France
		Debate: Management of BPH
		Office-Based Intervention (Urolift/iTEND/…) Dean Elterman, Canada
		OR (TURP, Green Light) Amanda Chung, Australia
1000-1100		Part 3: Mastering Early Career Challenges Moderator: Dean Elterman, Canada
1000-1020		Starting your career in…
		North America
		Europe Siska van Bruwaene, Belgium
		East Asia Sung Yong Cho, South Korea
		South Asia
		Discussion
1035-1042		Taking Control of Your Online Footprint Michael Leveridge, Canada
1042-1049		Research: International Collaborations for Young Urologists Todd Manning, Australia
1049-1056		Looking Back and Facing Forward: Building an Academic Career Peter Black, Canada

0800-1100

SYMP-06: SIU-ICUD Consultation on Congenital Lifelong Urology

Room: 3F Shilla 4
Co-Chairs: Dan Wood, United States / Hadley Wood, United States
Social Media Moderator: Imogen Patterson, Australia

At the end of this session, the learner will:

Describe basic tenets of the transition process from pediatric to adult urologic care in patients with congenital urological diseases, including when and how to initiate the process, the role of multiple disciplines, and the key stakeholders
Describe the challenges surrounding urological care in adolescence, including physiologic and biologic changes that impact care and how to manage these issues through transition to adult care
Understand and describe approach to genital revision surgery within the context of periadolescence and young adulthood, including fertility (male and female) and pregnancy (for females) consultation
Understand triggers and implement surveillance in adult life for patients with congenital neuropathic bladder, including cancer surv
Interpret renal function through aging using creatinine-based and non-creatinine based techniques, when and how to involve nephrologic consultation, and considerations for kidney transplant
Describe and implement routine age-related urologic surveillance in individuals with congenitally abnormal urologic systems, including treatments for BPH, prostate cancer, hypogonadism and pelvic prolapse

0800-0830		The Basics of Transition Rosalia Misseri, United States
0830-0900		Challenges to the Paradigms in Paediatric Practice Based on the Long-term View John Wiener, United States
0900-0930		Genital/Urethra – Sexual Function and Fertility Gunter De Win, Belgium and UK
0930-1000		Complications in Adulthood for Patients with Paediatric Reconstruction Stephanie Kielb, United States
1000-1030		Upper Tract Considerations Elizabeth Yerkes, United States
1030-1100		Age-related Urological Problems in the Complex Urological Patient Claire Taylor, United Kingdom

0800-1100

SYMP-03: World Chinese Urology (in Mandarin)

Room: 3F Shilla 1/2/3
Co-Chairs: Yinghao Sun, China / Li-Ping Xie, People's Republic of China

0800-0806		Welcome and Introduction Yinghao Sun, China
0806-0919		Urological Oncology Liqun Zhou, China Moderator: Yinghao Sun, China
0806-0815		Development History of Infection and Inflammation Group of CUA Junhua Zheng, China
0815-0824		Selection of Pelvic and Postperitoneal Lymph Node Dissection to Treat Metastatic Lymph Nodes after Radical Prostatectomy Xin Gao, China
0824-0833		The Safety Consensus of Prostate Cancer Endocrine Therapy Haifeng Wang, China
0833-0842		Better Castration Level, More Survival Benefits Qian Zhang, China
0842-0851		Changing Landscape In the Management of Metastatic Castration Sensitive Prostate Cancer Liqun Zhou, China
0851-0900		Prostate Cancer Treatment in China: Changing Paradigm and Current Consensus Yao Zhu, China
0900-0909		The Clinical Application and Progress of GnRH Antagonist in Prostate Cancer Hormonal Treatment Xin Gao, China
0909-0918		Cognitive Targeted Prostate Biopsy Haifeng Wang, China
0918-0954		Urolithiasis Moderators Jiwen Cheng, China Guohua Zeng, China
0918-0927		Multiple Tract PCNL for Complex Renal Stones Guohua Zeng, China
0927-0936		The Advantages of Moses Technology in SMP Guohua Zeng, China
0936-0945		What We Have Done: The Progress of Upper Urinary Tract Calculi Management in China Shaogang Wang, China
0945-0954		Sun’s Tip-flexible Semi-rigid Ureteroscope: State of the Art Rui Chen, China
0954-1057		Minimally Invasive Urology Moderator: Nianzeng Xing, China
0954-1003		Technical Innovations of Changhai Hospital in the Treatment of Renal Cell Carcinoma Chao Zhang, China
1003-1012		1500 Cases of Robotic Urological Surgery: A Single Center Experience Dong Wang, China
1012-1021		The Future Development Trends of Endoscop Nianzeng Xing, China
1021-1030		Evolution and Development of Laparoscopic Equipment Junhua Zheng, China
1030-1039		Bipolar Plasmakinetic Transurethral Endoscopic Enucleation of BPH over 200g: With 24 Cases Zhihui Zou, China
1039-1048		BPH Management Strategy with 180W Greenlight Laser Shaogang Wang, China
1048-1057		Experience on Treatment of Pelvic Organ Prolapse and Stress Incontinence with Transperineal Mesh Yaoguang Zhang, China

1100-1300

SYMP-07: World Journal of Urology Symposium

Room: 3F Shilla 1/2/3
Co-Chairs: Rajeev Kumar, India / Guillaume Ploussard, France

1100-1130		The Structure of a Paper Guillaume Ploussard, France
1130-1200		Why do My Papers Get Rejected? Rajeev Kumar, India
1200-1220		What Does an Editor Want From Reviewers? Joseph A. Smith, United States
1220-1240		Identifying Pseudo-Journals Kwangsung Park, South Korea
1240-1300		The Role of Mid-Level Journals Yoshihiko Tomita, Japan

1100-1600

KUA-MP: KUA Moderated ePoster Session (English)

Room: 5F Goguryeo 1/2/3

To view a list of scheduled presentations for this session, please click here.

1100-1205		KUA-01: Prostate Cancer Moderators Hong Koo Ha, South Korea Jae Young Park, South Korea
1205-1305		KUA-02: Functional Urology and Investigational Research Moderator: Jong Bo Choi, South Korea
1305-1425		KUA-03: Andrology, Infertility, Endourology and Pediatric Urology Moderators Hyung Joon Kim, South Korea Hyun Jun Park, South Korea
1425-1540		KUA-04: Prostate and Other Genitourinary Cancers Moderators Ja Hyeon Ku, South Korea Dongdeuk Kwon, South Korea

1200-1300

SYMP-08: Innovations in MIS Technology

Room: 3F Shilla 4
Chair: Gyung Tak Mario Sung, South Korea

1200-1220		Application of 8K Endoscope and AI Navigation in Surgery Makoto Hashizume, Japan
1220-1240		Treating Prostate Cancer Non-Invasively Li-Ping Xie, People's Republic of China
1240-1300		MIS Technology in BPH Treatment Henry Ho, Singapore

1200-1500

SYMP-09: Urology in the Middle East

Room: 4F Baekje 6

1200-1230		Overactive Bladder
1200-1215		Sacral Neuromodulation
1215-1230		Botox Injection Ajay Singla, United States
1230-1300		Varicocelectomy in Non-obstructive Azoospermia
1230-1245		Yes Mohammad Ali Sadighi Gilani, Iran
1245-1300		No Sidney Glina, Brazil
1300-1330		Peyronie’s Disease Management
1300-1315		Surgical Management Joel Gelman, United States
1315-1330		Non-Surgical Management Mohammad Ali Zargar, Iran
1330-1400		Prenatal Hydronephrosis
1330-1345		Obstructive John Wiener, United States
1345-1400		Non-Obstructive Gholamreza Pourmand, Iran
1400-1430		Adrenal Mass
1400-1415		Preoperative Evaluation Chiruvella Mallikarjuna, India
1415-1430		Surgical Management M. Hadi Radfar, Iran
1430-1500		Ureteropelvic Junction Obstruction
1430-1445		Laparoscopic:
1445-1500		Robotic Mahesh R. Desai, India

1330-1500

SYMP-10: Pan African Urological Surgeons' Association Symposium

Room: 3F Shilla 4
Co-Chairs: Serigne Magueye Gueye, Senegal / Mohamed Jalloh, Senegal

1330-1430		SESSION I: On the Clinical Frontier Moderators Serigne Magueye Gueye, Senegal Mobile Kampanga, Democratic Republic of Congo
1330-1340		Quinolone Resistance among Patients Undergoing Urogenital Stone Treatment in Steve Biko Academic Hospital Evelyn Mmapula Moshokoa, South Africa
1340-1350		A Case for House: Pediatric Ureteric Stricture Disease Lisa Kaestner, South Africa
1350-1400		Challenges in the Management of Penile Cancer in Resource Limited Environment Allen Chiura, Zimbabwe
1400-1410		Prostatic Vaporization TURIS - One Day Surgery: African Experience (About 530 Cases) Redouane Rabii, Morocco
1410-1420		A Review of Bladder Cancer in Africa: A Different Disease with a Distinct Presentation and Management
1420-1430		Survival from Metastatic Prostate Cancer in DRC Punga Maole, Democratic Republic of Congo
1430-1500		SESSION II: Strategies to advance Urology in Africa Moderator: Alex Danso, Zimbabwe
1430-1440		Minimally Invasive Surgery in Africa: Evidence-Based Practice Cyril Kamadjou, Cameroon
1440-1450		Strategic Plan to Eliminate Obstetric Fistula in Africa Serigne Magueye Gueye, Senegal
1450-1500		Simulation as Endourology Training Tool in Africa? Mohamed Jalloh, Senegal

1330-1630

SYMP-11: European Association of Urology Symposium

Room: 3F Shilla 1/2/3
Chair: Manfred Wirth, Germany

1330-1400		Molecular Substaging of Urothelial Cancer: The Future Arnulf Stenzl, Germany
1400-1430		The Role of miRNA in Oncogenesis and Progression of Prostate Cancer Manfred Wirth, Germany
1430-1500		Management of the Underactive Bladder: A Contemporary Update
1500-1530		Treatment of Localized Prostate Cancer—When: Active Surveillance, Focal Therapy, Radical Prostatectomy or Radiotherapy Manfred Wirth, Germany
1530-1600		Pelvic Anatomy for Minimally and Open Surgery: Better Functional Results after Cystectomy and Prostatectomy Arnulf Stenzl, Germany
1600-1630		Contemporary Management of Stress Urinary Incontinence in the Female: Synthetic Slings and Beyond?

1500-1630

SYMP-12: Joint Kenya Association of Urological Surgeons and South African Urological Association Symposium

Room: 3F Shilla 4
Co-Chairs: Shingai Mutambirwa, South Africa / Saeed R. Samnakay, Kenya

		Squamous Cell Carcinoma of the Urethra: Management Dilemma Willis Oyieko, Kenya
		Managing Ureteric Injuries During Ureteroscopy
		TRUS Guided Prostate Biopsies: Kenyan Experience SNK Waweru, Kenya
		Brachytherapy for Early Prostate Cancer in Kenya P M-Ngugi, Kenya
		Occupation Bicycle-Riding as a Cause of ED in East Africa Edward Mugalo, Kenya
		Dilemma of Managing Undescended Testis in Puberty and Post-Puberty Age-Groups in Kenya M Omar, Kenya
		Outcomes of Panurethral Stricture Management at Kenyatta National Hospital, Nairobi Willy Otele, Kenya
		An Online Survey on the Practice of Simple Prostatectomy for BPO in Kenya Patrick Mburugu, Kenya
		Epidemiology of Stones in Developing Countries Ismail Khalaf, Egypt
		Challenges in South African Stone Management Lisa Kaestner, South Africa
		Ultra-Low Cost Wireless Endoscope Camera John Lazarus, South Africa

Friday, October 05

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0730-0830

MC01: Master Class 1—How to Manage Recurrent Non-Muscle Invasive Bladder Cancer

Room: 4F Baekje 2/3/4
Co-Chairs: Maurizio Brausi, Italy / Thomas Guzzo, United States

At the end of this session, the learner will:

Understand optimal transurethral resection techniques for bladder cancer and new technologies to enhance the efficacy and safety of TUR such as blue light cystoscopy
Understand the appropriate definition of BCG unresponsive bladder cancer and subsequent treatment options for this subset of patients
Understand the indications for early cystectomy in the non-muscle invasive bladder cancer patient

0730-0745		Transurethral Resection (TUR) of Bladder Tumors in 2018: Did Urologists Improve It? Trinity Bivalacqua, United States
0745-0750		Discussion
0750-0805		Optimal Intravesical Therapy Maurizio Brausi, Italy
0805-0810		Discussion
0810-0825		Early Cystectomy for High-Risk NMIBC: Is It Appropriate? Seth Lerner, United States
0825-0830		Discussion

0730-0830

MC02: Master Class 2—Surgical Guidelines and Techniques for Kidney Stones

Room: 3F Shilla 4
Co-Chair: Mahesh R. Desai, India

At the end of this session, the learner will:

Be familiar with different standard and new techniques of PCNL.
Be able to recognize the complications of PCNL (complications of patient positioning, Access to the kidney and bleeding after PCNL)
Know indications and technique of Laparoscopic pyelolithotomy and nephrolithotomy.
Be able to diagnose complications of laparoscopic stone management and their management.
Know how to dilate ureter and to place ureteral sheath in the ureter safely.
Know the indications of transureteral management of renal pelvic and calcyeal stone (RIRS)
Be familiar with how to use proper laser to disintegrate the stone.

0730-0750		PCNL (Standard, Mini, Micro): Pursuit of Excellence in Management of Staghorn Calculus Mahesh R. Desai, India
0750-0810		Laparoscopic Management in Stone Disease
0810-0830		RIRS: An Update Emrah Yürük, Turkey

0730-0830

MC03: Master Class 3—How to Achieve Best Quality MR/US Fusion Prostate Biopsy

Room: 5F Goguryeo 1
Co-Chairs: Jeremy Grummet, Australia / Ardeshir Rastinehad, United States

At the end of this session, the learner will:

Understand the basics of MR imaging of the prostate
Assess and select patients for MR US fusion guided biopsy
Understand of how MR US Fusion guided biopsy technology works and how it is used to perform targeted biopsies.

0730-0745		Reading Multiparametric Prostate MRI and Reporting Using PI-RADS v2 Byung Kwan Park, South Korea
0745-0800		Patient Selection and Preparation for MR/US Fusion Prostate Biopsy Manish Patel, Australia
0800-0815		Technique for MR/US Fusion Prostate Biopsy Ardeshir Rastinehad, United States
0815-0830		Discussion Discussants Jeremy Grummet, Australia Byung Kwan Park, South Korea Ardeshir Rastinehad, United States

0830-1110

PL01: Plenary 1

Room: 5F Baekdu A+B
Honorary Chairs: Gopal Badlani, United States / Badrinath Konety, United States / Rajeev Kumar, India
Social Media Moderators: Justin Chee, Australia / John Davis, United States

At the end of this session, the learner will:

Learn the varied germline and somatic mutations in urologic cancers.
Associate therapeutic response and clinical outcomes with differing mutational profiles.
Gain insight into the development of new biomarker assays that will stratify patients.
Realize that molecular classifications of urologic cancers are driving therapeutic selection.
Identify patients suitable for active surveillance for prostate cancer
Discuss the emerging role of radical prostatectomy for oligo-metastatic prostate cancer
Describe the components of enhanced recovery pathways in urological surgery
Describe several currently applied therapeutic modalities that use a tissue-engineered construct.
Understand design of implantable tissue-engineered grafts that exhibit characteristics consistent with the physiology and function of the equivalent healthy native tissue.
Explore the use of porcine small intestinal submucosa (SIS) and bladder ECM grafts, which have garnered significant attention.
Comprehend how seeded constructs vs. unseeded technology has potential as an application in tissue engineering.
Discuss ongoing clinical trials (Urological Disease Clinical Trials) such as:
- Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora.
- Multisystem Cell Therapy for Improvement of Urinary Continence
- Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
- Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures

0830-0915		Interpretation and Clinical Implication of Cancer Genetics in Uro-Oncology Moderator: Christopher Evans, United States
		Prostate Cancer Seok Soo Byun, South Korea
		Renal Cell Carcinoma Bradley Leibovich, United States
		Bladder Cancer Piyush Agarwal, United States
0915-1000		Oncology Updates Moderator: Monish Aron, United States
		PRIAS-JAPAN Study Mikio Sugimoto, Japan
		Oligomets RARP Isaac Kim, United States
		ERAS Protocol Jay Shah, United States
		Oncology Updates - Audience Polling Monish Aron, United States
1000-1020		SIU-Dr. Mostafa M. Elhilali Lecture
		Urologists vs Urinary Bugs: Time for a Truce?
1020-1040		Panel—Cell Therapy and Constructs: Why Is It Not Yet In Clinical Use? Moderator: Karl-Dietrich Sievert, Germany Panelists Yun Seob Song, South Korea James Yoo, United States
1040-1055		European Association of Urology Lecture
		What is the Role of Radical Prostatectomy in Locally Advanced and Oligo Metastatic Prostate Cancer? Manfred Wirth, Germany
1055-1110		State of the Art Lecture
		Advances in Robotic Surgery in 2018 Koon Ho Rha, South Korea

0845-1145

INN: Cambridge Prostate MRI Workshop

Room: 3F Shilla 1/2/3
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom

Based on the Cambridge Prostate MRI & Biopsy Workshop.

Pre-registration required for this workshop.

1110-1130

Break in Exhibit Hall

Room: 3F Hanra

1115-1130

SIU@U: SIU@U Session | SIU Academy Awards

Room: SIU Booth
Host: Dean Elterman, Canada

1130-1300

MP-01: Moderated ePoster Session 01—Outstanding Abstracts

Room: 5F Goguryeo 1
Moderators: Sanjay Kulkarni, India / Kyu-Sung Lee, South Korea / Simon Tanguay, Canada

To view a list of scheduled presentations for this session, please click here.

1130-1300

JS01: Joint SIU-SURS Symposium: Robotic Innovations in Urology

Room: 5F Baekdu A+B
Co-Chairs: John Davis, United States / René Sotelo Noguera, United States
Social Media Moderator: Ardeshir Rastinehad, United States

At the end of this session, the learner will:

State what's new in urologic robotic Surgery
Recognize emerging procedures in robotic surgery
Recall technical tips and tricks for current robotic procedures

1130-1142		Novel Intraoperative Imaging Modalities during Robotic Surgery Lance Hampton, United States
1145-1157		Robotic Partial Nephrectomy: How to Optimize Renal Function Preservation Riccardo Autorino, United States
1200-1212		The Rise of Robotic Simple Prostatectomy: Tips and Tricks René Sotelo Noguera, United States
1215-1227		Novel Approaches for Robotic Radical Prostatectomy Koon Ho Rha, South Korea
1230-1242		Intracorporeal Urinary Diversion: An Effective Alternative John Davis, United States
1245-1257		Robotic Single Port Surgery is Coming Back: New Systems and New Techniques Eddie Chan, Hong Kong

1130-1130

JS02: Joint SIU-Endourology Symposium

Room: 5F Baekdu C
Co-Chairs: Olivier Traxer, France / Michael Wong, Singapore
Social Media Moderator: Sung Yong Cho, South Korea

At the end of this session, the learner will:

Identify the factors behind the choices for buying your next Ureteroscope and Nephroscope using a debate format for discussion.
Redefine the Optimal Holmium Laser settings for endourological procedures today.
Learn and apply the lessons learned in the optimal usage of Ureteral Access Sheaths in the past decade.

1130-1150		Panel Discussion—The Evolution of Ureteroscopy: Robotic, Disposable, Micro-URS—Are We Off Track?
		I am a Traditional Urologist: Reusable Devices Michael Grasso, United States
		I am a “Fed-up with Breakage” Urologist: Single-Use and Robotic Devices Petrisor Aurelian Geavlete, Romania
1150-1210		Debate—Does Tract Size and Intra-renal Pressures Matter in PCNL?
		I like Normal Size Sung Yong Cho, South Korea
		I like a Smaller Size Norberto Bernardo, Argentina
1210-1230		The Final Statement on Ureteral Access Sheath—Does it Do More Harm than Good? Michael Wong, Singapore
1230-1250		Have We Optimized Holmium Laser Settings in Urology? Olivier Traxer, France
1250-1300		Discussion

1215-1615

INN: SIU Innovators MRI-TRUS Fusion Hands-On Course

Room: 3F Shilla 1/2/3
Co-Chairs: Peter Black, Canada / Christof Kastner, United Kingdom

Pre-registration is required for this course.

1300-1415

Lunch Break

Room: 3F Hanra

1415-1545

IC01: Instructional Course 01—Medical Treatment of CRPC

Room: 3F Shilla 4
Chair: Damien Bolton, Australia

At the end of this session, the learner will:

Describe the natural course of prostate cancer with particular emphasis upon the acquisition of castrate resistant disease.
Explain the implications of castrate resistance on the management of prostate cancer in regard to medical and surgical needs.
Be aware of specific recommendations and guidelines for patient management within this area of practice.
Understand the roles for recently approved therapeutics for CRPC.
Contrast the mechanisms of action and clinical efficacy of such therapeutics for CRPC.
Appraise immunosuppressive agents and other novel therapeutic groups used in the treatment of CRPC.
Integrate advances in bone health management into patient care.
Proactively manage comorbidities, and also the side effects of medications used for the treatment of CRPC.

1415-1420		Introduction Damien Bolton, Australia
1420-1435		Chemotherapy for CRPC: Which Patient and When? Nathan Lawrentschuk, Australia
1435-1450		Immunotherapy for Castrate Resistant Prostate Cancer Sung Kyu Hong, South Korea
1450-1505		Clinical Implications of Genomic Sequencing in CRPC Christopher Evans, United States
1505-1520		How to Initiate Urologist-Directed Management of CRPC Manish Patel, Australia
1520-1530		Discussion

1415-1545

IC02: Instructional Course 02—Male Infertility and Varicoceles

Room: 4F Baekje 2/3/4
Co-Chairs: Joel Marmar, United States / Mohammad Ali Sadighi Gilani, Iran

At the end of this session, the learner will:

Identify and differentiate the current tests that are available to evaluate the basis of infertility associated with varicoceles.
Understand the pathologic factors associated with varicoceles.
Compare and evaluate the current treatments for the correction of varicoceles.

1415-1420		Introduction Joel Marmar, United States
1420-1435		Drug Therapy for Varicocele Induced Infertility Sidney Glina, Brazil
1435-1450		Varicocelectomy and DNA Fragmentation Gholamreza Pourmand, Iran
1450-1505		Surgery is Useful in Azoospermic Men William Huang, Taiwan
1505-1520		Doing the Surgery Right Joel Marmar, United States
1520-1535		Pregnancy Data on Varicocele Surgery Rajeev Kumar, India
1535-1545		Audience Polling Joel Marmar, United States

1415-1545

MP-02: Moderated ePoster Session 02—Basic Science

Room: 5F Goguryeo 1
Moderators: Piyush Agarwal, United States / Ji-Kan Ryu, South Korea

To view a list of scheduled presentations for this session, please click here.

1415-1545

MP-03: Moderated ePoster Session 03—BPO/LUTS

Room: 5F Goguryeo 2
Moderators: Henry Ho, Singapore / Seung-June Oh, South Korea

To view a list of scheduled presentations for this session, please click here.

1415-1545

MP-04: Moderated ePoster Session 04—Stones

Room: 5F Goguryeo 3
Moderator: Sung Yong Cho, South Korea

To view a list of scheduled presentations for this session, please click here.

1415-1545

CONT01: Controversies in Urology 1—Urethroplasty

Room: 5F Baekdu C
Co-Chairs: Frank Burks, United States / Sanjay Kulkarni, India
Social Media Moderator: Justin Chee, Australia

At the end of this session, the learner will:

Have a better understanding of the use of tissue grafts and tissue flaps for the management of urethral stricture disease.
Increase their knowledge with regards to the use of grafting in urethroplasty and anastomotic urethroplasty.
Have an improved understanding of the benefits and advantages of a simple vs elaborated perineal approach for urethroplasty.
Gain a better understanding of the management of lichen sclerosis with a single stage urethroplasty vs two stage urethroplasty.

1415-1418		Introduction
1418-1438		Bulbar Urethra: Graft vs. Anastomosis
		Graft Justin Chee, Australia
		EPA Michael Coburn, United States
1438-1458		Grafts vs. Flaps
		Grafts Jeremy Myers, United States
		Flaps
1458-1518		Penile Urethral Stricture due to Lichen Sclerosus: Two Stage vs Single Stage Repair
		Two Stage Ramon Virasoro, United States
		Single Stage Dmitriy Nikolavsky, United States
1518-1538		PFUD: Simple vs. Elaborated Perineal Approach
		Simple Francisco E. Martins, Portugal
		Elaborated Anthony Mundy, United Kingdom
1538-0000		Summary and Closing Remarks

1415-1735

SMV01: Surgical Masters Videos 1—Laparoscopy

Room: 5F Baekdu A+B
Co-Chairs: Koon Ho Rha, South Korea / René Sotelo Noguera, United States

At the end of this session, the learner will:

Recall with the most commonly performed laparoscopic procedures.
Recognize/prevent complications during laparoscopic surgery
Manage intraoperative laparoscopic complications

1415-1435		Robotic Radical Prostatectomy Gyung Tak Mario Sung, South Korea
1435-1455		Robotic Simple Prostatectomy René Sotelo Noguera, United States
1455-1515		Robotic Pyeloplasty and Ureteral Reconstruction Mihir Desai, United States
1515-1535		Laparoscopic Radical Nephrectomy: Step-by-Step Chiruvella Mallikarjuna, India
1535-1555		Robotic Partial Nephrectomy Koon Ho Rha, South Korea
1555-1615		Robotic Kidney Transplant Presenter: René Sotelo Noguera, United States
1615-1635		Robotic Salvage Prostatectomy: Tips and Tricks Monish Aron, United States
1635-1655		Laparoscopic and Robotic Adrenalectomy Rajeev Kumar, India
1655-1715		Laparoscopic and Robotic Vesico-Vaginal Fistula Repair René Sotelo Noguera, United States
1715-1735		Endoscopic Inguinal Lymphadenectomy Victor Enrique Corona Montes, Mexico

1545-1605

Break in Exhibit Hall

Room: 3F Hanra

1605-1735

DEMO: Demo Session | Tips and Tricks in FURS

Room: 4F Baekje 6

Pre-registration is required for this session.

1605-1735

IC03: Instructional Course 03—Treatment of Urolithiasis in 2018: Could We Do It Better?

Room: 3F Shilla 4
Chair: Kevin Lu, Taiwan

At the end of this session, the learner will:

Describe, in general, the current status of urolithiasis in real-world, and accurate evaluation of patients with urolithiasis
Contrast risks and benefits of different treatment options and recognize how to avoid and manage treatment-associated complications
Establish efficient facility and team to perfect RIRS and PNL step by step
Discuss treatment options with patients to inform decision-making

1605-1610		Opening Remarks Kevin Lu, Taiwan
1610-1630		Urolithiasis in Clinical Vignettes: More than Meets the Eye Kevin Lu, Taiwan
1630-1650		Tips and Tricks of Retrograde Intrarenal Surgery (RIRS): How To Establish and Perfect an Efficient Facility Hung-Chieh Chiu, Taiwan
1650-1710		PNL in 2018: Where Are We Headed? Less is More? Hsin-Wei Shih, Taiwan
1710-1730		Panel Discussion
1730-1735		Summary and Conclusion Kevin Lu, Taiwan

1605-1735

MP-05: Moderated ePoster Session 05—Prostate Cancer: Basic Science

Room: 5F Goguryeo 1
Moderators: Wun-Jae Kim, South Korea / Arturo Mendoza-Valdes, Mexico

To view a list of scheduled presentations for this session, please click here.

1605-1735

MP-06: Moderated ePoster Session 06—Adrenal and Andrology

Room: 5F Goguryeo 2
Moderators: Ajay Nehra, United States / Kwangsung Park, South Korea

To view a list of scheduled presentations for this session, please click here.

1605-1735

MP-07: Moderated ePoster Session 07—Imaging/Radiology

Room: 5F Goguryeo 3
Moderators: Peter Hammerer, Germany / Seung-Hyup Kim, South Korea

To view a list of scheduled presentations for this session, please click here.

1605-1735

IC04: Instructional Course 04—Female Urethral Reconstruction

Room: 4F Baekje 2/3/4
Chair: Kurt McCammon, United States

At the end of this session, the learner will:

Describe the incidence and evaluation of female urethral strictures
Describe the surgical options including dorsal and ventral Grafts and flaps.
Review the etiology of traumatic strictures and their treatment.

1605-1610		Introduction Kurt McCammon, United States
1610-1630		Epidemiology Evaluation and Diagnosis
1630-1650		Surgical Management Kurt McCammon, United States
1650-1710		Traumatic Urethral Stricture Nikhil Khattar, India
1710-1735		Case Presentations Discussants Nikhil Khattar, India Kurt McCammon, United States

1605-1735

CONT02: Controversies in Urology 2—Testis Cancer

Room: 5F Baekdu C
Co-Chairs: Jens Bedke, Germany / Andrea Necchi, Italy
Social Media Moderator: Shomik Sengupta, Australia

At the end of this session, the learner will:

Decide the optimal treatment strategy in testis cancer clinical stage I
Identify risk factors of relapse in CSI and will be able to judge the prognosis in TC CSI.
Repeat currently used biomarkers and be able to recognize new biomarkers in TC for the future.

1605-1650		Management of Clinical Stage I in Seminoma and Non-seminoma:
		Surveillance Karim Touijer, United States
		RPLND Yao Zhu, China
		Chemo Andrea Necchi, Italy
1650-1710		The Future of Biomarkers to Guide Therapy and Follow-up Jens Bedke, Germany
1710-1735		Question and Answer

Saturday, October 06

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0730-0830

SIU General Assembly

Room: 5F Goguryeo 2

0730-0830

MC04: Master Class 4—Bladder Cancer: Robot Assisted Laparoscopic Radical Cystectomy and Urinary Diversions

Room: 4F Baekje 2/3/4
Co-Chairs: Ashish M. Kamat, United States / Raj Pruthi, United States

At the end of this session, the learner will:

Identify the role of robotics in bladder cancer surgery including indications and approaches to robotic cystectomy.
Recognize potential complications associated with robotic bladder cancer surgery (including diversion) and develop skills and approaches to avoid such complications.
Be able to perform complex robotic bladder cancer surgery (cystectomy and urinary diversion) with a comprehension of the work-up and surgical steps of the procedures.

0730-0735		Introduction Ashish M. Kamat, United States Raj Pruthi, United States
0735-0745		Key Steps of Robotic Radical Cystoprostatectomy and ePLND (Extirpative) Gagan Gautam, India
0745-0755		Key Steps of Robotic Anterior Pelvic Exenteration (RARC in XRT Patient) Jeffrey Nix, United States
0755-0800		Question and Answer
0800-0810		Intracorporeal Ileal Conduit Mihir Desai, United States
0810-0820		Intracorporeal Neobladder Giuseppe Simone, Italy
0820-0825		Question and Answer
0825-0830		Summary Ashish M. Kamat, United States Raj Pruthi, United States

0730-0830

MC05: Master Class 5—Stones: Surgical Guidelines and Techniques (Ureter)

Room: 3F Shilla 4
Co-Chairs: Norberto Bernardo, Argentina / Anthony Chi-Fai Ng, Hong Kong

At the end of this session, the learner will:

The role of safety guidewire during the uretroscopy
The controversies related to the use of access sheath during ureteroscopy
The use of stents before and after ureteroscopy
The latest development in rigid ureteroscopy

0730-0742		To Stent or Not To Stent? Sung Yong Cho, South Korea
0745-0757		Sheath vs. No Sheath (RIRS) Anthony Chi-Fai Ng, Hong Kong
0800-0812		Is Safety Guide Wire Still Needed? Norberto Bernardo, Argentina
0815-0827		Is the Rigid Ureteroscope Still Alive? Shuji Isotani, Japan

0730-0830

MC06: Master Class 6—Advanced Diagnostic and Interventional Imaging in Urology

Room: 5F Goguryeo 1
Co-Chairs: Krishnanath Gaitonde, United States / Dan Rukstalis, United States

At the end of this session, the learner will:

Understand the clinical application of multiparametric ultrasound as an emerging diagnostic and interventional modality for prostate cancer
Be able to define the role of PET and flouroscence imaging in the management of recurrent and advanced prostate cancer
Understand how imaging can be utilized to characterize tissue architecture in determining the malignant potential of renal tumors

0730-0735		Introduction Krishnanath Gaitonde, United States Dan Rukstalis, United States
0735-0750		Multiparametric Ultrasound in Diagnosis of Prostate Cancer Dan Rukstalis, United States
0750-0805		PET and Fluorescence Imaging for Recurrent/Advanced Prostate Cancer Jun Miki, Japan
0805-0820		Advances in Renal Imaging for Tumor Tissue Characterization Krishnanath Gaitonde, United States
0820-0830		Question and Answer

0800-1530

NURS: 4th Global Urology Nurses’ Symposium

Room: 4F Baekje 6
Chair: Kay Talbot, Australia

0800-0805		Welcome
0805-0845		The Transition from Trans Rectal Prostate Biopsy to Transperineal Prostate Biopsy–Implications on Care Jeremy Grummet, Australia
0845-0930		Does Confusion Continue to Surround Catheter Care? Khatijah Abdullah, Malaysia Azad Hassan Abdul Razack, Malaysia
0930-1015		Lower Urinary Tract Symptoms (LUTS) including Benign Prostate Hypertrophy (BPH) Jaspreet S. Sandhu, United States
1015-1045		Moderated ePoster Presentations
1015-1020		NURS-01: The Effect of Kegel Exercise with Different Intensities on Patients with Stress Urinary Incontinence Presenter: Xiaoqin Chen, China
1020-1025		NURS-02: Effect of Omaha System in the Continuity Nursing of Patients with Sacral Nerve Regulator Implantation Presenter: Xin Cheng, China
1025-1030		NURS-03: Short-term Removal Protocol of Indwelled Urethral Catheter Applied in Partial Nephrectomy Patients After Surgery Presenter: Jie Cao, China
1030-1035		NURS-04: Study of Perioperative Fast Track Surgery Nursing for Benign Prostatic Hyperplasia Treated with 1470nm Diode Laser Enucleation of the Prostate Presenter: Li Zhang, China
1035-1040		NURS-05: Younger Patients is More Easy to Get Depressive Disorders by Non-neoplastic Nephrectomy Presenter: Shanhua Mao, China
		Break and ePoster Viewing
		Oral Abstract Presentations Moderator: Vashti Livingston, United States
1100-1110		NURS-06: Evaluation of the Service Outcomes of the Urology Nurse Clinic for Female Patients with Urinary Retention Presenter: Kwok Kin Leung, China
1110-1120		NURS-07: Evaluation of Nutrition Support in the Enhanced Recovery after Surgery Program for Perioperative Prostate Cancer Patients Presenter: Xiaoling Qu, China
1120-1130		NURS-08: The Study on the Process Optimization of Painless Transperineal Prostate Biopsy under TRUS Guidance Presenter: Husheng Li, China
1130-1140		NURS-09: The Application of Bundle Nursing in the Prevention of Postoperative Urination Dysfunction of Orthotopic Neobladder Presenter: Xuemei Li, China
1140-1150		NURS-10: Qualitative Analysis of Factors Influencing the Prostate Cancer Patients’ Participation Degree Toward the Decision-Making Process of Operative Treatment Presenter: Jie Cao, China
1150-1200		NURS-11: Does Postoperative Rehabilitation for Radical Cystectomy call for Enhanced Recovery after Surgery? A Systematic Review and Meta-Analysis Presenter: Jun Xiao, China
1200-1210		NURS-12: A Nursing Intervention for Enhancing the Self-efficacy and Life Quality of Patients with Bladder Cancer and Urostomy in Beijing, China Presenter: Jing Huang, China
		Break and ePoster Viewing
1315-1415		Wound Management: Current Generation Dressings Vashti Livingston, United States
1415-1435		Managing Quality of Life for Men on Androgen Deprivation Therapy Kay Talbot, Australia
1435-1510		Discussing Sexual Function after Treatment for Prostate Cancer Chi Kwok Chan, China
1455-1530		Creating and Managing Patient Expectations Haengah Lee, South Korea Arveen Kalapara, Australia Haeng Ah Yi, South Korea
1530-1530		Adjourn

0830-1100

PL02: Plenary 2

Room: 5F Baekdu A+B
Honorary Chairs: Peter Hammerer, Germany / Simon Tanguay, Canada
Social Media Moderator: Dean Elterman, Canada

At the end of this session, the learner will:

Delineate the overlapping nature of functional urology and the impact of that overlap with recognized lower urinary tract syndromes
Define and understand the variability of pelvic floor and sphincteric dysfunction associated with Spinal Cord Injury
Appreciate the causes, impacts and treatments for nocturia in adults
Understand the concept of the topics discussed and would be much more confident in taking the decisions in their day to day practice
Be in a position to make the decision on which treatment modality would be the ideal one
Be able to reduce the damage of flexible ureteroscopes in day to day practice
Understand the philosophy of managing those stones by various experts

0830-0920		Functional Urology Moderator: Roger Dmochowski, United States
0830-0845		Is the Detrusor Muscle the Target of Therapy for Lower Urinary Tract Symptoms?
0845-0900		External Sphincter Behavior in SCI, Dysfunctional Voiding and Pelvic Floor Weakness John Heesakkers, The Netherlands
0900-0920		Nocturia Alan Wein, United States
0920-1020		Stones Moderators Chiruvella Mallikarjuna, India Guohua Zeng, China
		Algorithm to Treat Calyceal Diverticular Stones: PCNL vs RIRS? Olivier Traxer, France
		Tactics to Reduce Scope Damage: Ideal Versus Practical Pankaj Maheshwari, India
		Panel: Perioperative Management of Retained Stones—Complicated Cases Moderator: Madhu Sudan Agrawal, India Panelists Joel Aldana, Philippines Norberto Bernardo, Argentina John Denstedt, Canada
1020-1030		SIU Best Video Award Honorary Chair: Simon Tanguay, Canada
1030-1045		Confederación Americana de Urología Lecture
		Robotic Assisted Radical Cystectomy: Present and Future Alejandro Rodriguez, United States
1045-1100		Urological Association of Asia Lecture
		Introduction Allen W. Chiu, Taiwan
		Physical Energy Therapy for Prostate Cancer Yinghao Sun, China

0845-1145

INN: Cambridge Prostate MRI Workshop

Room: 3F Shilla 1/2/3
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom

Based on the Cambridge Prostate MRI & Biopsy Workshop.

Pre-registration required for this workshop.

1100-1130

Break in Exhibit Hall

Room: 3F Hanra

1110-1125

SIU@U: SIU@U uTalks | Tracing the Tumors: The Hype of Molecular Imaging

Room: SIU Booth
Speaker: Karim Touijer, United States

1130-1300

DEMO: Demo Session | Tips and Tricks in FURS

Room: 3F Shilla 4

Pre-registration is required for this session.

1130-1300

JS03: Joint SIU-GURS Symposium: Male Urogenital Trauma

Room: 5F Baekdu A+B
Chair: Michael Coburn, United States

At the end of this session, the learner will:

Describe the surgical options as well as pros and cons for penile reconstruction either phalloplasty or penile transplant.
Understand the up to date management of GU trauma
Describe the treatment options for genital lymphedema

1130-1200		Penile Transplant vs Phallic Reconstruction
		Transplant André van der Merwe, South Africa
		Reconstruction
		Rebuttal André van der Merwe, South Africa
		Rebuttal
		Questions and Discussion
1200-1220		Genital Lymphedema: Lessons Learned from Ghana Ben Adusei, Ghana
1220-1240		Fournier’s Gangrene: Acute and Chronic Ramon Virasoro, United States
1240-1300		Genitourinary Trauma Update Michael Coburn, United States

1130-1300

JS04: Joint SIU-ESOU-SUO Symposium

Room: 5F Baekdu C
Co-Chairs: Maurizio Brausi, Italy / Christopher Evans, United States

At the end of this session, the learner will:

Understand the utility of prostate cancer biomarkers.
Recognize the cost of biomarker assays and their potential cost benefit.
Comprehend the strengths and limitations of MRI as an initial test for elevated PSA.
Recognize the balance of treatment of renal cell cancer with toxicities in the elderly patient.
Realize the benefits and limitations of bladder sparing surgery for muscle invasive bladder cancer as it particularly relates to the elderly patient.

1130-1210		Biomarkers and MRI Pre-biopsy in the Patient with an Elevated PSA Moderator: Jason Letran, Philippines
		Biomarkers Are Cost Effective and Useful in Patient Selection Derya Tilki, Germany
		MRI Should Be Performed in All Patients Prior to Biopsy Jun Hyuk Hong, South Korea
		Case Panel Discussion
1210-1230		Nephron Sparing Surgery in the Patient Over 75 Years of Age Moderator: Christopher Evans, United States
		State of the Art Lecture: Nephron Sparing Surgery in the Patient Over 75 Years of Age Peter Mulders, The Netherlands
		Discussion
1230-1300		Issues and Controversies in Bladder Cancer Moderator: Maurizio Brausi, Italy
		High Grade T2 UCC of the Bladder in a 75-Year-Old Patient—Debate: Bladder Sparing Surgery
		Pro Rainy Umbas, Indonesia
		Con Badrinath Konety, United States
		Discussion

1215-1615

INN: SIU Innovators MRI-TRUS Fusion Hands-On Course

Room: 3F Shilla 1/2/3
Co-Chairs: Peter Black, Canada / Christof Kastner, United Kingdom

Pre-registration is required for this course.

1300-1415

Lunch Break

Room: 3F Hanra

1415-1545

IC05: Instructional Course 05—Upper Tract TCC Management In 2018: Current Perspective

Room: 3F Shilla 4

At the end of this session, the learner will:

Identify the newer concepts in the upper tract urothelial carcinoma in terms of biological behaviour
Appreciate the limitations of the current investigative modalities and treatment
Analyze the concept of conservative treatment in upper tract UC
Critically analyze the results of adjuvant chemotherapy in the post nephreuretectomy status in upper tract UC

1415-1435		Is it an Aggressive Disease? Raj Pruthi, United States
1435-1455		Diagnosis and Staging: The Pitfalls and the Challenges Jean de la Rosette, Türkiye
1455-1515		Conservative Management in Upper Tract TCC
1515-1535		Adjuvant Therapy after Radical Nephreureterectomy: Where Is the Evidence Badrinath Konety, United States

1415-1545

MP-08: Moderated ePoster Session 08—Pediatric Urology and Infections

Room: 5F Goguryeo 1
Moderators: Christopher Cheng, Singapore / Kwanjin Park, South Korea

To view a list of scheduled presentations for this session, please click here.

1415-1545

MP-09: Moderated ePoster Session 09—Prostate Cancer: Intervention

Room: 5F Goguryeo 2
Moderators: Jun Hyuk Hong, South Korea / Peter Mulders, The Netherlands

To view a list of scheduled presentations for this session, please click here.

1415-1545

MP-10: Moderated ePoster Session 10—Bladder and Penile Cancer

Room: 5F Goguryeo 3
Moderators: Ioannis Gkialas, Greece / Sun Il Kim, South Korea

To view a list of scheduled presentations for this session, please click here.

1415-1545

IC06: Instructional Course 06—Donor Nephrectomy

Room: 4F Baekje 2/3/4
Co-Chairs: Hyuk jin Cho, South Korea / Aneesh Srivastava, India

At the end of this session, the learner will:

Recall how to prepare a donor for surgery and how to perform a safe surgery.
List precautions required in selecting a potential donor as per the current international guidelines and standards and describe various surgical options from open to minimally invasive surgery to remove the kidney.
Apply adequate surgical knowledge that would help them to safely assist and perform such surgical procedures.

1415-1435		Robotic and Laparoscopic Donor Nephrectomy Hyuk jin Cho, South Korea
1435-1443		Hand-Assisted Laparoscopic Retrieval Ki Soo Lee, South Korea
1445-1500		Open Donor Nephrectomy Aneesh Srivastava, India
1500-1520		The Current International Guidelines on the Care of the Kidney Donor Sanjay Pandey, India
1520-1535		Summation and Audience Polling Aneesh Srivastava, India
1535-1545		Discussion/Case Presentation

1415-1545

CONT03: Controversies in Urology 3—Urethral Diverticulum

Room: 5F Baekdu C
Chair: Roger Dmochowski, United States
Social Media Moderator: Amanda Chung, Australia

At the end of this session, the learner will:

Define the use of imaging modalities in the diagnosis of urethral diverticula
Understand the potential for non-surgical therapy for urethral diverticula
Select and enumerate the best surgical options for urethral diverticula
List the functional outcomes of importance for any intervention for urethral diverticula

1415-1435		Evaluation Including Use of Advanced Imaging John Heesakkers, The Netherlands
1435-1455		The Case for Conservative Managements Gopal Badlani, United States
1455-1515		Surgical Options and Results – Is There a Best Way? Janice Cheng, Australia
1515-1535		Functional Outcomes and How to Optimize, with Emphasis on Continence and Sexual Function Satoru Takahashi, Japan
1535-1545		Discussion

1415-1545

SMV02: Surgical Masters Videos 2—Male Voiding Complications after Prostate Treatment

Room: 5F Baekdu A+B
Co-Chairs: Jaspreet S. Sandhu, United States / Ajay Singla, United States

At the end of this session, the learner will:

To understand the urinary complications following prostate surgery.
To learn about Bladder neck contracture after prostatectomy and its related complications and management.
To learn regarding male sling and management of complications.
To learn about adjustable male sling and management of complications following prostatectomy.
To learn about the management of post-prostatectomy incontinence by AUS implantation and related complications.

1415-1435		Artificial Urinary Sphincter Placement Including Trouble Shooting AUS Malfunction Sean P. Elliott, United States
1435-1455		Transobturator Male Sling Placement Kurt McCammon, United States
1455-1515		Adjustable Male Sling Placement Javier Angulo, Spain
1515-1535		Open/Robotic Anastomotic Stricture Repair Jeremy Myers, United States

1430-1500

SIU@U: SIU@U Session | uChallenge—Residents Rapid Fire Q&A

Room: SIU Booth
Host: Dean Elterman, Canada

1545-1600

SIU@U: SIU@U uTalks | Why is Perioperative Patient Education Important?

Room: SIU Booth

Sunday, October 07

Please click on the session titles to view the session details when available.

Session will be presented on the SIU@U App included with your congress registration.

0730-0830

IC07: Instructional Course 07—Management of Urinary Complications after Prostatectomy

Room: 5F Goguryeo 1
Chair: Jaspreet S. Sandhu, United States

At the end of this session, the learner will:

Understand complex etiology of urinary incontinence after prostatectomy
Identify issues in management of incontinence after prostatectomy.
Develop an algorithm for management of recalcitrant anastomotic strictures
Identify treatment options for urinary fistula including reconstructive procedures and indications for urinary diversion

		Faculty William J. Lynch, Australia
0820-0830		Audience Polling and Discussion Jaspreet S. Sandhu, United States

0730-0830

MC07: Master Class 7—Case-Based Management: Bladder Cancer

Room: 4F Baekje 2/3/4
Co-Chairs: Badrinath Konety, United States / Giuseppe Simone, Italy

At the end of this session, the learner will:

Recall indication to neoadjuvant chemotherapy before radical cystectomy, proper extent of pelvic lymph node dissection, selection of patient tailored urinary diversions.
Analyze reasons behind differences in approach to presented cases.
Recognize high quality evidences and technical supports for managing muscle invasive bladder cancer patients

		Panelists Piyush Agarwal, United States Monish Aron, United States Michael Rink, Germany
0730-0735		Introduction Badrinath Konety, United States Giuseppe Simone, Italy
0735-0745		Case 1: Pro and cons of Neoadjuvant Chemotherapy cT2/cN0/M0 –> NACT –> leucopenia and delayed radical cystectomy Michael Rink, Germany
0745-0755		Case 2: Optimal Extent of PLND cT3/cN3/M0 –> NACT –>partial response (cT0/N2/M0) Piyush Agarwal, United States
0755-0810		Case 3: Sex Sparing RC: Open? Robotic? cT2/cN0/M0, young female –> Video-based Presentation (Sex Sparing and Neobladder) Monish Aron, United States
0810-0825		Case 4: Continent Cutaneous Urinary Diversions cT4a/cN0/M0, young male/female –> NACT –> Partial Response but Persistent Disease at Prostate/Urethral Margin: Conduit or Continent Diversion?
0825-0830		Conclusions Badrinath Konety, United States Giuseppe Simone, Italy

0730-0830

MC08: Master Class 8—Case-Based Management of Complex Stones

Room: 3F Shilla 4
Co-Chairs: John Denstedt, Canada / Athanasios (Thanos) Papatsoris, Greece

At the end of this session, the learner will:

Be familiar with indications and options for the management of complex renal and ureteral calculi.
Establish an effective algorithm for management of complex stones including cystine and radiolucent stones, calculi in anomalous anatomy and in anticoagulated patients.
Understand technical aspects and variations in approaches to URS and PCNL in complex stone cases.

0730-0745		Anticoagulation and Stones Norberto Bernardo, Argentina
0745-0800		Stones in Pregnancy Anthony Chi-Fai Ng, Hong Kong
0800-0815		Anomalous Kidney
0815-0830		Diversion and Stones Guohua Zeng, China

0830-1110

PL03: Plenary 3

Room: 5F Baekdu A+B
Honorary Chairs: Jean de la Rosette, Türkiye / Sanjay Kulkarni, India
Social Media Moderators: Sung Yong Cho, South Korea / Imogen Patterson, Australia / Faysal Yafi, United States

At the end of this session, the learner will:

Summarize the history of robotic systems to the present.
Compare the different robotic systems available for urologic surgery.
Discuss the various urological procedures that can be done on the different robotic systems
Summarize worldwide perspectives on Men's Health
Relate the importance of Men's Health in Urological Practice and Urological Research
Identify the aspects of Men's Health they could focus on to improve their individual practices or as research objectives.
Review basic laser physics and current prostate enucleation techniques.
Discuss Bipolar, Robotic, Holmium-LEP (HoLEP), Aqua Ablation, Thulium-LEP (ThuLEP), Greenlight-LEP (GreenLEP) and traditional techniques (TURP)
Summarize current literature with respect to functional outcomes and complications.

0830-0855		New Robotic Devices John Davis, United States
0855-0925		Men's Health Panel Moderator: Serigne Magueye Gueye, Senegal Panelists Lukman Hakim, Indonesia Ajay Nehra, United States
0925-1010		BPH Panel: Enucleation Techniques Moderator: Jaspreet S. Sandhu, United States
		Bipolar Li-Ping Xie, People's Republic of China
		Robotic Thomas Guzzo, United States
		Holmium Anil Kumar Varshney, India
		Aqua Ablation Peter Gilling, New Zealand
		GreenLight Laser Vincent Misrai, France
		Is There a Role for Open? Oussama Elhage, United Kingdom
1010-1025		SIU-Albert Schweitzer Award Lecture
		Is the Spirit of Albert Schweitzer Outdated in 2018? Alain Le Duc, France
1025-1040		American Urological Association Lecture
		Bladder Exstrophy: Global Solutions for a Global Problem Aseem Shukla, United States
1040-1055		Pan-African Urological Surgeons' Association Lecture
		Surgical Management of BPH in Africa: The Way Forward Mobile Kampanga, Democratic Republic of Congo
1055-1110		Global Philanthropic Committee Presentation Simon Tanguay, Canada

1110-1130

Break

Room: 5F Baekdu D

1130-1300

INN: Resident Mentoring Session

Room: 3F Shilla 1/2/3
Moderator: M. Hadi Radfar, Iran

The session will feature 9 experts paired up with up to 3 trainees. The group of trainees will have 8 minutes with each expert to ask questions and seek advice regarding career planning and goals.

Experts

Jens Bedke, Germany
Damien Bolton, Australia
Joseph Chin, Canada
John Davis, United States
Seok Ho Kang, South Korea
Sanjay Kulkarni, India
Pilar Laguna, Türkiye
Athanasios (Thanos) Papatsoris, Greece
André van der Merwe, South Africa

1130-1300

JS05: Joint SIU-ICS Symposium

Room: 5F Baekdu A+B
Co-Chairs: Elise De, United States / Sherif Mourad, Egypt

At the end of this session, the learner will:

Identify global considerations in neurogenic bladder and fistula, and begin to apply these considerations in care of patients from these regions, whether in home clinics or in mission work.
Describe special considerations in the care of patients with spina bifida transitioning from adolescence to adulthood and to guide best care within his or her practice set up.
Recognize the impact of pelvic floor disorders, dysfunctional voiding, and pelvic pain and to return to practice with more developed and multidisciplinary strategies for the best approach to these patients.

1130-1135		Introduction Elise De, United States Sherif Mourad, Egypt
1135-1155		Panel—Neurogenic Bladder
		Global Considerations: Long-Term Follow Up and Underdeveloped Countries Giovanni Mosiello, Italy
		Transitional Urological Management of Adolescents with Spina Bifida Yasuhiko Igawa, Japan
1155-1225		State of the Art Lectures
		Dysfunctional Voiding Gopal Badlani, United States
		Fistula in 2018: Complex Surgical Management Sherif Mourad, Egypt
		Clinical Implications of Underactive Bladder Kyu-Sung Lee, South Korea
1225-1255		Roundtable—Pelvic Pain
		Diagnostic Algorithm Elise De, United States
		Non-Medical Approaches to the Treatment of Pelvic Pain Talli Rosenbaum, Israel
		Holistic Treatment of Pelvic Pain: Colorectal Perspective Massarat Zutshi, United States
1255-1300		Question and Answer

1130-1300

COMP: Complications—This Is How I Manage It: Audience-Submitted Cases

Room: 5F Baekdu C
Co-Chairs: Anil Mandhani, India / Amlesh Seth, India
Social Media Moderator: Phillip M. Pierorazio, United States

Registered participants will be solicited for case submissions via e-mail in advance of the Congress. The Chair will review submissions and make case selections. Cases will be presented to the audience and discussed/debated with experts.

At the end of this session, the learner will:

Apply the knowledge to avoid certain steps in surgery to prevent complications.
Recall steps to deal with such untoward incidences if at all they surface during surgery or intervention

		Story after Percutaneous Nephrolithotomy Mahesh R. Desai, India
		I Aspirated Bile after an Initial Puncture while Doing PCNL: What Next? Preetham Dev, India
		Is Gastric Conduit an Option for Urinary Diversion? Anthony Mundy, United Kingdom
		High Drain Output in Kidney Transplant Recipient in Immediate Post Operative Period: What Shall I Do? Anil Mandhani, India
		Ghost Bladder: An Enigma! Sunil B Moteria, India
		Flank Pain after Laparoscopic Appendectomy Nagesh Kamat, India
		IVC Bleeding during Lap Radical Nephrectomy for RCC with IVC Thrombus Chiruvella Mallikarjuna, India
		Hem-o-lok Clip Over the Main Renal Artery: What Shall I Do? Prahara Yuri, Indonesia
		Rapid-Fire Round Amlesh Seth, India
		Expert Panel John Denstedt, Canada Dan Wood, United States

1300-1415

Lunch Break

Room: 5F Baekdu D

1415-1545

IC08: Instructional Course 08—Penile Prosthesis

Room: 4F Baekje 2/3/4
Chair: Faysal Yafi, United States

At the end of this session, the learner will:

Prepare and set up for various techniques of penile prosthesis surgery
Perform standard and complex penile prosthesis procedures
Evaluate and manage complications related to penile prosthesis surgery

		Faculty Lawrence Jenkins, United States Sung Hun Park, South Korea Faysal Yafi, United States
		Topics
		Overview, work-up and management options for erectile dysfunction
		Overview of different penile prostheses (malleable, 2- and 3-piece inflatable implants)
		Patient preparation and positioning for penile prosthesis surgery
		Different approaches for penile prosthesis placement (penoscrotal, infrapubic, penoscrotal)
		Minimally invasive penile prosthesis placement under local anesthesia
		Different approaches for reservoir placement
		Prosthesis placement in Peyronie’s disease and fibrosis
		Management of intraoperative complications
		Management of post-operative complications
		Mini-Jupette for the management of climacturia
		Dual artificial urinary sphincter and penile prosthesis placement
		Follow-up of patients after penile prosthesis placement

1415-1545

MP-11: Moderated ePoster Session 11—Voiding Dysfunction

Room: 5F Goguryeo 1
Moderators: Joon Chul Kim, South Korea / Karl-Dietrich Sievert, Germany

To view a list of scheduled presentations for this session, please click here.

1415-1545

MP-12: Moderated ePoster Session 12—Kidney & Ureteral Cancer

Room: 5F Goguryeo 2
Moderators: Woong Kyu Han, South Korea / Athanasios (Thanos) Papatsoris, Greece

To view a list of scheduled presentations for this session, please click here.

1415-1545

MP-13: Moderated ePoster Session 13—Reconstruction and Trauma

Room: 5F Goguryeo 3
Moderators: Kurt McCammon, United States / Hong Seok Park, South Korea

To view a list of scheduled presentations for this session, please click here.

1415-1735

RF: Residents' Forum: Moderated ePoster Session

Room: 4F Baekje 6
Moderators: Sang Don Lee, South Korea / Imogen Patterson, Australia

To view the list of scheduled presentations, please click here.

1415-1545

IC09: Instructional Course 09—Neoadjuvant Therapy as the Foundation for Immunotherapy Advances in Muscle-Invasive Urothelial Bladder Carcinoma (MIUBC)

Room: 3F Shilla 4
Chair: Andrea Necchi, Italy

At the end of this session, the learner will:

Understand and apply the criteria for patient inclusion in neoadjuvant trials of ICI (i.e., to include cisplatin-ineligible patients only or all comers).
Discuss what is the optimal number of immunotherapy administrations, optimal methods to stage patients and evaluate clinical response to immunotherapy in bladder tumors, toxicity and side effects exposure prior to radical cystectomy, role of maintenance therapy after surgery
Discuss the translational findings that the neoadjuvant therapy model may generate in muscle-invasive bladder cancer
Know which are the ongoing trials in the neoadjuvant and adjuvant setting of bladder cancer and delineate the pathways of clinical research in the field of urothelial bladder carcinoma

1415-1435		The Landscape of Clinical Trials in Early-Stage MIUBC Jens Bedke, Germany
1435-1455		Translating Clinical Findings to Scientific Advances: The Neoadjuvant Paradigm in MIBC
1455-1515		Challenges in Developing Immunotherapy Trials in MIBC: Lessons Learned from an Ongoing Trial Andrea Necchi, Italy
1515-1545		Clinical Case Discussions Discussants Jens Bedke, Germany Andrea Necchi, Italy

1415-1545

CONT04: Controversies in Urology 4—MR/US Fusion Prostate Biopsy: Best Approach

Room: 5F Baekdu C
Chair: John Davis, United States
Social Media Moderator: Jeremy Grummet, Australia

At the end of this session, the learner will:

Compare the relative strengths and limitations of transrectal versus transperineal fusion biopsy systems
Recognize patient level impact from specialty biopsies
Recall options for patients with clinical risk of cancer but no clear targets on MRI imaging

1415-1425		Introduction— High Impact Decisions in Specialty Prostate Biopsies John Davis, United States
1425-1440		Transperineal Approach Sunao Shoji, Japan
1440-1455		Transrectal Approach Robert Reiter, United States
1455-1510		In-Bore MR-Guided Approach Lance Hampton, United States
1510-1525		What To Do If There Is No Clear Target Jeremy Grummet, Australia
1525-1545		Cases and Discussion Discussants John Davis, United States Jeremy Grummet, Australia Lance Hampton, United States Robert Reiter, United States Sunao Shoji, Japan

1415-1735

SMV03: Surgical Masters Videos 3—Female Urology

Room: 5F Baekdu A+B
Co-Chairs: John Heesakkers, The Netherlands / Vincent Tse, Australia

At the end of this session, the learner will:

Recognize the various surgical approaches to the female urethra and how they are applied
Consider when to use vaginal flap techniques and grafts such as buccal mucosa and fascial sling in urethral reconstruction
Comprehend the challenges involved in transvaginal mesh removal and when to perform full versus partial removal
Identify factors associated with successful vesicovaginal fistula repair
Discuss continent urinary diversion solutions

1415-1430		Dorsal Onlay Technique of Female Urethroplasty Arabind Panda, India
1430-1445		Endoscopic Attempts at Mesh Removal Gopal Badlani, United States
1445-1500		Closure of a Vesico-Vaginal Fistula John Heesakkers, The Netherlands
1500-1515		Huge VVF via Vaginal Route Ajit Vaze, India
1515-1530		Stage III and IV Cystocele Repair Supported by Fascial Sling Janice Cheng, Australia
1530-1545		Female Urethral Stricture-Review and Transurethral Technique to Minimize Morbidity Justin Chee, Australia
1545-1600		Dorsal Approach to Multilobar Urethral Diverticulum Repair Vincent Tse, Australia
1600-1615		Continent Urinary Diversion Sherif Mourad, Egypt
1615-1630		Open Implantation of an Artificial Sphincter in a Female Karl-Dietrich Sievert, Germany
1630-1735		Discussion

1545-1605

Break

Room: 5F Baekdu D

1605-1735

IC10: Instructional Course 10—Urethroplasty: What to Do and How to Do It

Room: 4F Baekje 2/3/4
Chair: Francisco E. Martins, Portugal

At the end of this session, the learner will:

Determine criteria for selection of the most appropriate technique for urethral reconstruction based on location and etiology of the stricture
Determine the best onlay graft urethroplasty for each individual situation
Select the best therapeutic approach for complex and reoperative cases, such as single-stage or staged reconstruction
Define the resources available for each individual stricture

1605-1607		Introduction and Overview Francisco E. Martins, Portugal
1607-1632		Ventral Buccal Mucosa Graft (BMG) Urethroplasty for Short Strictures and Dorsal BMG Urethroplasty for Long Strictures Francisco E. Martins, Portugal
1632-1657		Anastomotic Urethroplasty for Pelvic Fracture Urethral Injury (PFUI) and AUA Stricture Guidelines: What You Need to Know Sanjay Kulkarni, India
1657-1722		Two-Stage Urethroplasty for Post-Hypospadias Repair Strictures and Redo Urethroplasty: What to Do Matthias Hofer, United States
1722-1735		Discussion and Polling Francisco E. Martins, Portugal

1605-1735

MP-14: Moderated ePoster Session 14—UTUC and Miscellaneous

Room: 5F Goguryeo 1
Moderators: Jens Bedke, Germany / Byong Chang Jeong, South Korea

To view a list of scheduled presentations for this session, please click here.

1605-1735

MP-15: Moderated ePoster Session 15—Prostate Cancer

Room: 5F Goguryeo 2
Speaker: Nianzeng Xing, China
Moderator: Dongdeuk Kwon, South Korea

To view a list of scheduled presentations for this session, please click here.

1605-1735

MP-16: Moderated ePoster Session 16—PNL, Training and Transplants

Room: 5F Goguryeo 3
Moderators: Bum Soo Kim, South Korea / André van der Merwe, South Africa

To view a list of scheduled presentations for this session, please click here.

1605-1735

IC11: Instructional Course 11—Work-up and Management of Prostate Cancer Following Local Radiation Failure

Room: 3F Shilla 4
Chair: Joseph Chin, Canada

At the end of this session, the learner will:

Identify potentially curative local salvage possibilities following radiation failure and be able to diagnosis local versus extra-pelvic recurrence following radiotherapy, using established (i.e. mpMRI) and emerging (e.g. PSMA PET) imaging techniques.
Formulate best treatment options for patients with recurrence after prostate radiotherapy, and to triage accordingly, being mindful of side effect profiles, indications and contraindications of different local salvage modalities.
Recognize the nuances regarding the technical aspects of salvage radical prostatectomy and the various minimally invasive therapies, for safe and efficient execution in the properly selected patients.
Be familiar with the outcomes and adverse effects of various salvage treatment modalities.

1605-1610		Introduction and General Overview Joseph Chin, Canada
1610-1625		Work-up • Local versus Distant Failure • PSA Kinetics • Imaging (emerging: PSMA PET, established: multiparametric MRI,) Glenn Bauman, Canada
1625-1725		Salvage Options for Localized Failures
		Salvage Prostatectomy/Salvage Cystoprostatectomy Yves Fradet, Canada
		Minimally Invasive Salvage Whole-Gland Ablative Procedures (Salvage Cryoablation/HIFU/ Interstitial Laser plus others Joseph Chin, Canada
		Focal Salvage Ablation Joseph Chin, Canada
		Brachytherapy for EBRT Failure Glenn Bauman, Canada
1725-1728		Summation Joseph Chin, Canada Yves Fradet, Canada
1728-1735		Questions and Discussion Joseph Chin, Canada

1605-1735

CONT05: Controversies in Urology 5—Renal Cancer: Management of Small Renal Masses in Elderly Patients

Room: 5F Baekdu C
Chair: Pilar Laguna, Türkiye

At the end of this session, the attendee will be able to:

Compare outcomes among the possible treatments of SRM in the Elderly
Summarize recent data available, including prevalence of RCC among SRMs
Analyze the outcomes and impact of HRQOL of different treatment options
State the current indications and factors that can balance the choice of the treatment

1605-0000		Introduction and Case Illustrations Pilar Laguna, Türkiye
1615-1635		Active Surveillance Phillip M. Pierorazio, United States
1635-1655		Ablation Seok Ho Kang, South Korea
1705-1725		Nephron-Saving Strategy Nobuyuki Hinata, Japan